Log in to save to my catalogue

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenop...

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenop...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04941037v1

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level

About this item

Full title

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level

Publisher

London: Springer London

Journal title

Osteoporosis international, 2024-04, Vol.35 (4), p.653-658

Language

English

Formats

Publication information

Publisher

London: Springer London

More information

Scope and Contents

Contents

Purpose
The main effect of anti-resorptive agents such as bisphosphonates is a reduction of bone resorption, with a consequent marked decrease of bone turnover. This post-hoc analysis investigated the changes of histomorphometric parameters of bone turnover after alendronate (ALN), according to the baseline turnover.
Methods
Ninety postmen...

Alternative Titles

Full title

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04941037v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04941037v1

Other Identifiers

ISSN

0937-941X

E-ISSN

1433-2965

DOI

10.1007/s00198-023-06972-8

How to access this item